Trending

ADHD

Re-envisioning mental health treatment using clinical VR

Re-envisioning mental health treatment using clinical VR

Skip Rizzo, PhD, research director for medical virtual reality at the University of Southern California’s Institute for Creative

X

Re-envisioning mental health treatment using clinical VR

https://pharmaphorum.com/digital/mental-health-treatment-using-clinical-virtual-reality/

Akili raises $110m to build its digital therapeutics pipeline

Akili raises $110m to build its digital therapeutics pipeline

Digital health player Akili has raised $110 million fourth-round funding, backed by a number of pharma groups, as

X

Akili raises $110m to build its digital therapeutics pipeline

https://pharmaphorum.com/news/akili-raises-110m-to-build-its-digital-therapeutics-pipeline/

Akili’s gaming therapy improves attention in ADHD kids

Akili’s gaming therapy improves attention in ADHD kids

Akili has published data backing the efficacy of its childhood attention-deficit hyperactivity disorder (ADHD) video game therapy EndeavorRx

X

Akili’s gaming therapy improves attention in ADHD kids

https://pharmaphorum.com/news/akilis-gaming-therapy-improves-attention-in-adhd-kids/

Akili presents new real-world data from therapeutic ADHD video game

Akili presents new real-world data from therapeutic ADHD video game

Akili has new data from its childhood hyperactivity therapeutic video game EndeavorRx, as the company builds a case

X

Akili presents new real-world data from therapeutic ADHD video game

https://pharmaphorum.com/news/akili-presents-new-real-world-data-from-therapeutic-adhd-video-game/

Retired NFL Linebacker Overcomes ADHD, Invests in Mental Health Platform Done

Retired NFL Linebacker Overcomes ADHD, Invests in Mental Health Platform Done

Mental health platform Done makes its debut

X

Retired NFL Linebacker Overcomes ADHD, Invests in Mental Health Platform Done

https://pharmaphorum.com/partner-content/retired-nfl-linebacker-overcomes-adhd-invests-in-mental-health-platform-done/

Akili’s ADHD digital therapy approved in Europe

Akili’s ADHD digital therapy approved in Europe

The European Medicines Agency has approved Akili’s ground-breaking digital therapy for attention deficit hyperactivity disorder (ADHD), which uses a video

X

Akili’s ADHD digital therapy approved in Europe

https://pharmaphorum.com/news/akilis-adhd-digital-therapy-approved-in-europe/

FDA approves first medical device ADHD treatment

FDA approves first medical device ADHD treatment

US regulators have given the green-light for the first medical device to treat attention deficit hyperactivity disorder (ADHD).

X

FDA approves first medical device ADHD treatment

https://pharmaphorum.com/news/fda-approves-neurosigma-adhd/

Teva and Neos settle over Cotempla patent dispute

Teva and Neos settle over Cotempla patent dispute

Teva and Neos Therapeutics have reached a confidential settlement and licensing agreement that resolves a patent dispute over

X

Teva and Neos settle over Cotempla patent dispute

https://pharmaphorum.com/news/teva-and-neos-settle-over-cotempla-patent-dispute/

Supernus says ADHD drug trounces rivals, but shares slide

Supernus says ADHD drug trounces rivals, but shares slide

Supernus Pharma has two phase III trials showing its attention-deficit hyperactivity disorder (ADHD) drug SPN-812 met its objectives,

X

Supernus says ADHD drug trounces rivals, but shares slide

https://pharmaphorum.com/news/supernus-says-adhd-drug-trounces-rivals-but-shares-slide/

1 2

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com